Valuation : Terumo Corporation

Market Cap 3,745B 23.41B 20.17B 18.92B 17.27B 32.53B 2,238B 32.63B 224B 87.56B 1,130B 87.9B 85.99B P/E 2027 *
19.6x
P/E 2028 * 19.6x
Enterprise Value 3,800B 23.75B 20.47B 19.19B 17.52B 33B 2,270B 33.11B 228B 88.84B 1,146B 89.18B 87.24B EV / Sales 2027 *
3.03x
EV / Sales 2028 * 2.79x
Free-Float
97.07%
Yield 2027 *
1.46%
Yield 2028 * 1.6%
1 day-0.82%
1 week-1.17%
Current month+9.25%
1 month+10.92%
3 months+5.81%
6 months+20.33%
Current year+11.85%
1 week 2,534
Extreme 2534
2,645.5
1 month 2,253
Extreme 2253
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,708
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.82%-1.17%-4.66%+18.23% 23.41B
+0.79%-3.58%-14.39%+9.42% 195B
+1.40%-2.27%-0.79%+12.09% 117B
+0.25%+1.25%+11.09%+78.52% 61.45B
-0.25%-1.97%+26.78%+53.11% 51.03B
+0.74%-1.29%-0.90%-32.69% 51.62B
+1.71%-1.65%+20.96%-8.53% 34.27B
+1.82%+2.98% - - 30.95B
-2.49%-4.42%+37.49%-16.34% 23.75B
+0.35%-1.74%-4.49%+2.61% 22.79B
Average +0.35%-1.10%+7.90%+12.94% 61.07B
Weighted average by Cap. +0.66%-1.84%+0.87%+15.35%

Financials

2027 *2028 *
Net sales 1,256B 7.85B 6.76B 6.34B 5.79B 10.91B 750B 10.94B 75.25B 29.36B 379B 29.47B 28.83B 1,336B 8.35B 7.2B 6.75B 6.16B 11.6B 798B 11.64B 80.05B 31.23B 403B 31.36B 30.67B
Net income 189B 1.18B 1.02B 953M 870M 1.64B 113B 1.64B 11.31B 4.41B 56.92B 4.43B 4.33B 191B 1.19B 1.03B 965M 881M 1.66B 114B 1.67B 11.45B 4.47B 57.65B 4.49B 4.39B
Net Debt 54.63B 341M 294M 276M 252M 474M 32.64B 476M 3.27B 1.28B 16.48B 1.28B 1.25B -16.66B -104M -89.76M -84.16M -76.83M -145M -9.96B -145M -998M -390M -5.03B -391M -383M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
28/08/26 JP¥2,539.00 -0.82% 3,795,800
27/08/26 JP¥2,560.00 -0.47% 2,949,800
26/08/26 JP¥2,572.00 -0.94% 3,286,000
25/08/26 JP¥2,596.50 +0.04% 3,106,200
24/08/26 JP¥2,595.50 +1.03% 3,082,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,539.00JPY
Average target price
3,133.08JPY
Spread / Average Target
+23.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock